SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Medifast Inc. – ‘10-Q’ for 9/30/22 – ‘EX-101.CAL’

On:  Thursday, 11/3/22, at 4:51pm ET   ·   For:  9/30/22   ·   Accession #:  1628280-22-28255   ·   File #:  1-31573

Previous ‘10-Q’:  ‘10-Q’ on 8/3/22 for 6/30/22   ·   Next:  ‘10-Q’ on 5/1/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 4/29/24 for 3/31/24   ·   2 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/03/22  Medifast Inc.                     10-Q        9/30/22   52:4.7M                                   Workiva Inc Wde… FA01/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.20M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
10: R1          Cover                                               HTML     68K 
11: R2          Condensed Consolidated Statements of Income         HTML     98K 
                (Unaudited)                                                      
12: R3          Condensed Consolidated Statements of Comprehensive  HTML     43K 
                Income (Unaudited)                                               
13: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    107K 
14: R5          Condensed Consolidated Balance Sheets               HTML     24K 
                (Parenthetical)                                                  
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     92K 
                (Unaudited)                                                      
16: R7          Condensed Consolidated Statements of Changes in     HTML    113K 
                Stockholders' Equity (Unaudited)                                 
17: R8          Summary of Significant Accounting Policies          HTML     23K 
18: R9          Inventories                                         HTML     26K 
19: R10         Earnings Per Share                                  HTML     39K 
20: R11         Share-Based Compensation                            HTML     82K 
21: R12         Leases                                              HTML     32K 
22: R13         Accumulated Other Comprehensive Income              HTML     24K 
23: R14         Financial Instruments                               HTML     65K 
24: R15         Debt                                                HTML     26K 
25: R16         Accelerated Share Repurchase ("Asr") Program        HTML     18K 
26: R17         Summary of Significant Accounting Policies          HTML     33K 
                (Policies)                                                       
27: R18         Inventories (Tables)                                HTML     26K 
28: R19         Earnings Per Share (Tables)                         HTML     37K 
29: R20         Share-Based Compensation (Tables)                   HTML     79K 
30: R21         Leases (Tables)                                     HTML     32K 
31: R22         Accumulated Other Comprehensive Income (Tables)     HTML     24K 
32: R23         Financial Instruments (Tables)                      HTML     62K 
33: R24         Inventories (Details)                               HTML     31K 
34: R25         EARNINGS PER SHARE - Computation of Basic and       HTML     55K 
                Diluted EPS (Details)                                            
35: R26         EARNINGS PER SHARE - Narrative (Details)            HTML     18K 
36: R27         SHARE-BASED COMPENSATION - Narrative (Details)      HTML     77K 
37: R28         SHARE-BASED COMPENSATION - Stock Options Activity   HTML     34K 
                (Details)                                                        
38: R29         SHARE-BASED COMPENSATION - Restricted Stock         HTML     40K 
                Activity (Details)                                               
39: R30         SHARE-BASED COMPENSATION - Summary of               HTML     38K 
                Performance-based Share Awards (Details)                         
40: R31         LEASES - Narrative (Details)                        HTML     29K 
41: R32         LEASES - Supplemental Cash Flow Information         HTML     25K 
                (Details)                                                        
42: R33         LEASES - Future Minimum Lease Commitments           HTML     34K 
                (Details)                                                        
43: R34         ACCUMULATED OTHER COMPREHENSIVE INCOME -            HTML     30K 
                Accumulated Other Comprehensive Income (Details)                 
44: R35         FINANCIAL INSTRUMENTS - Cash and Financial Assets   HTML     47K 
                That are Measured at Fair Value on a Recurring                   
                Basis for Each of the Hierarchy Levels (Details)                 
45: R36         FINANCIAL INSTRUMENTS - Narrative (Details)         HTML     18K 
46: R37         DEBT - Narrative (Details)                          HTML     42K 
47: R38         Accelerated Share Repurchase ("Asr") Program        HTML     20K 
                (Details)                                                        
50: XML         IDEA XML File -- Filing Summary                      XML     87K 
48: XML         XBRL Instance -- med-20220930_htm                    XML   1.15M 
49: EXCEL       IDEA Workbook of Financial Reports                  XLSX     78K 
 6: EX-101.CAL  XBRL Calculations -- med-20220930_cal                XML    119K 
 7: EX-101.DEF  XBRL Definitions -- med-20220930_def                 XML    229K 
 8: EX-101.LAB  XBRL Labels -- med-20220930_lab                      XML    912K 
 9: EX-101.PRE  XBRL Presentations -- med-20220930_pre               XML    510K 
 5: EX-101.SCH  XBRL Schema -- med-20220930                          XSD     81K 
51: JSON        XBRL Instance as JSON Data -- MetaLinks              245±   366K 
52: ZIP         XBRL Zipped Folder -- 0001628280-22-028255-xbrl      Zip    235K

‘EX-101.CAL’   —   XBRL Calculations — med-20220930_cal

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- Copyright 2022 Workiva -->
<!-- r:1ae599f9-ff00-4d75-90b9-110349ab0236,g:6d08fa26-e8d0-4031-9c9e-a858e7464a0f -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
<link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_98bc9125-eb0a-4202-8362-eb74dc4051ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bd54b8a2-8fce-4890-bd20-2dd22cf503f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_98bc9125-eb0a-4202-8362-eb74dc4051ff" xlink:to="loc_us-gaap_GrossProfit_bd54b8a2-8fce-4890-bd20-2dd22cf503f5" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9bbed8e0-06dd-4ecc-b506-0e0a520d91be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_98bc9125-eb0a-4202-8362-eb74dc4051ff" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9bbed8e0-06dd-4ecc-b506-0e0a520d91be" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_40e42bbe-2a74-4a80-8608-284fe8a44ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0e2dcc74-90a3-4ee8-bd8f-f63f26dcbb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_40e42bbe-2a74-4a80-8608-284fe8a44ff0" xlink:to="loc_us-gaap_Revenues_0e2dcc74-90a3-4ee8-bd8f-f63f26dcbb18" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_819348de-be45-44bb-961d-c9d8826918d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_40e42bbe-2a74-4a80-8608-284fe8a44ff0" xlink:to="loc_us-gaap_CostOfRevenue_819348de-be45-44bb-961d-c9d8826918d6" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b8f6d6e9-74a7-44f2-a954-bc8941e1c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c4c6bd96-79f5-4632-93c0-71085eb610a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b8f6d6e9-74a7-44f2-a954-bc8941e1c4ec" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c4c6bd96-79f5-4632-93c0-71085eb610a8" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_082d1439-98c4-4f2a-8996-f8dd2d8d8081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b8f6d6e9-74a7-44f2-a954-bc8941e1c4ec" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_082d1439-98c4-4f2a-8996-f8dd2d8d8081" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_beedcb0e-761b-4128-a0a9-59082ad921a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_00b20fd5-1e26-4907-a544-7a5d814eba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_beedcb0e-761b-4128-a0a9-59082ad921a8" xlink:to="loc_us-gaap_OperatingIncomeLoss_00b20fd5-1e26-4907-a544-7a5d814eba4d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3d196858-7be0-40b1-8d79-883d00964921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_beedcb0e-761b-4128-a0a9-59082ad921a8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3d196858-7be0-40b1-8d79-883d00964921" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aee9b548-90d1-4bf7-859c-4891a0d5e65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb8c9b63-63a7-438d-aa46-052b02175eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aee9b548-90d1-4bf7-859c-4891a0d5e65a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fb8c9b63-63a7-438d-aa46-052b02175eb2" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_279fda0d-8335-4fa7-a111-b22dfc73a6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aee9b548-90d1-4bf7-859c-4891a0d5e65a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_279fda0d-8335-4fa7-a111-b22dfc73a6f4" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
<link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fd531838-9670-4f72-bd05-4ab99037165a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_970b47c1-c3a5-4923-a074-ecf5285f0a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fd531838-9670-4f72-bd05-4ab99037165a" xlink:to="loc_us-gaap_NetIncomeLoss_970b47c1-c3a5-4923-a074-ecf5285f0a95" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_18e9aee3-6553-4ac8-9a38-02afad39f5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fd531838-9670-4f72-bd05-4ab99037165a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_18e9aee3-6553-4ac8-9a38-02afad39f5dc" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_891d9e3d-afed-4d08-87fc-b59ab05bb8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_cd0e3c68-82c8-4dda-815e-823aee9d7fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_891d9e3d-afed-4d08-87fc-b59ab05bb8bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_cd0e3c68-82c8-4dda-815e-823aee9d7fd9" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a58e66ce-690e-4522-9d89-2117c2829619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_891d9e3d-afed-4d08-87fc-b59ab05bb8bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a58e66ce-690e-4522-9d89-2117c2829619" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
<link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_66f97c2b-ad2d-48d3-83e0-906c4295f886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_66f97c2b-ad2d-48d3-83e0-906c4295f886" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05129f99-131c-4368-9b9f-28e93fcb58f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05129f99-131c-4368-9b9f-28e93fcb58f6" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_090951f2-08e0-4e69-ba36-184145af3837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:to="loc_us-gaap_CommonStockValue_090951f2-08e0-4e69-ba36-184145af3837" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3db204b2-8bf3-4e14-930b-0e88f38ecb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ee5c2359-48b9-4d70-8651-be7618ca996a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3db204b2-8bf3-4e14-930b-0e88f38ecb57" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3faa2391-4757-4968-8812-85d2ffca2f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_AssetsCurrent_3faa2391-4757-4968-8812-85d2ffca2f32" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e0ba27ad-4810-48c9-bd7e-4456433004c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e0ba27ad-4810-48c9-bd7e-4456433004c7" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e8679c06-9b50-42e6-96c6-d32f1ba7af36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e8679c06-9b50-42e6-96c6-d32f1ba7af36" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4e69d76e-84a7-463d-937d-de0b1e0d51db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4e69d76e-84a7-463d-937d-de0b1e0d51db" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fb655c0f-8bfa-4d9a-8366-718ee5ffea60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94acf971-5e70-4c86-8ffd-8b420ca64fc6" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fb655c0f-8bfa-4d9a-8366-718ee5ffea60" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_58f5de0b-f826-4a55-9d2c-7287e7e68671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_ShortTermInvestments_58f5de0b-f826-4a55-9d2c-7287e7e68671" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c4ea6be6-32fd-40fe-bec0-e1aac1005ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_InventoryNet_c4ea6be6-32fd-40fe-bec0-e1aac1005ac3" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_bdae8a16-b09d-4534-9206-3f03b24c82e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_PrepaidTaxes_bdae8a16-b09d-4534-9206-3f03b24c82e7" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a84600a0-5f77-42ca-bc0b-1ae1313510f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a84600a0-5f77-42ca-bc0b-1ae1313510f4" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3f1aadf-ef35-4e2f-bc24-32cfeab47812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_791dfc02-ed5b-4db0-a1e1-218458eb3baa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3f1aadf-ef35-4e2f-bc24-32cfeab47812" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e3b85f-e333-44f7-8d53-b5a24ba6227d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f305d33c-5a8d-40d1-946f-f850c3abdb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e3b85f-e333-44f7-8d53-b5a24ba6227d" xlink:to="loc_us-gaap_Liabilities_f305d33c-5a8d-40d1-946f-f850c3abdb8b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_639494c6-4dcf-4b4f-8af1-49a67993ecd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0e3b85f-e333-44f7-8d53-b5a24ba6227d" xlink:to="loc_us-gaap_StockholdersEquity_639494c6-4dcf-4b4f-8af1-49a67993ecd9" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5148fa80-60d7-4ca6-9edf-ad252660eb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d94fd7eb-35c1-443a-9d89-2d0bf92298c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5148fa80-60d7-4ca6-9edf-ad252660eb55" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d94fd7eb-35c1-443a-9d89-2d0bf92298c6" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_864b7d45-759c-4b07-935f-eda82ee81843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5148fa80-60d7-4ca6-9edf-ad252660eb55" xlink:to="loc_us-gaap_LinesOfCreditCurrent_864b7d45-759c-4b07-935f-eda82ee81843" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8f524c9a-26f3-4e5a-b68f-07d7397f3228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5148fa80-60d7-4ca6-9edf-ad252660eb55" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8f524c9a-26f3-4e5a-b68f-07d7397f3228" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_36199173-e861-44e2-ad7c-5682b91e7ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_612d977d-1b17-4b42-b676-38ec0e84105e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36199173-e861-44e2-ad7c-5682b91e7ede" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_612d977d-1b17-4b42-b676-38ec0e84105e" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9ab0d794-0c37-4f40-9686-2932debd7bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36199173-e861-44e2-ad7c-5682b91e7ede" xlink:to="loc_us-gaap_LiabilitiesCurrent_9ab0d794-0c37-4f40-9686-2932debd7bdf" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="med-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
<link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1834fab6-9291-4954-a671-672d05c18e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1079be9d-4724-496f-a9e6-0a2a54f9e5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1834fab6-9291-4954-a671-672d05c18e42" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1079be9d-4724-496f-a9e6-0a2a54f9e5c9" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_699527a3-b297-4877-99c4-ee2ba505ce97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1834fab6-9291-4954-a671-672d05c18e42" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_699527a3-b297-4877-99c4-ee2ba505ce97" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_283bb76c-6020-437b-8224-2364963f64ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_283bb76c-6020-437b-8224-2364963f64ae" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a67e605-a402-4d9b-a810-30e963daa1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a67e605-a402-4d9b-a810-30e963daa1de" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8225b91d-d616-473d-a0a9-3b1024f717ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8225b91d-d616-473d-a0a9-3b1024f717ba" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eacd294d-6cfe-46ca-b61c-deb3513b3363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_12420b0a-0fe5-486c-86df-7419e270dc99" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eacd294d-6cfe-46ca-b61c-deb3513b3363" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76314941-3182-4b77-b6f6-235fda2e6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_NetIncomeLoss_76314941-3182-4b77-b6f6-235fda2e6e08" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d8db07af-08ce-4345-9164-88089a9a6be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d8db07af-08ce-4345-9164-88089a9a6be6" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash_dfd3e68a-20b7-4d91-82d9-359747a4ab23" xlink:href="med-20220930.xsd#med_OperatingLeaseExpenseNonCash"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_med_OperatingLeaseExpenseNonCash_dfd3e68a-20b7-4d91-82d9-359747a4ab23" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_65edf2fe-b745-4a57-aeff-aca0099dc2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_ShareBasedCompensation_65edf2fe-b745-4a57-aeff-aca0099dc2d7" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_med_AmortizationOfPremiumOnInvestmentSecurities_348a915e-2b56-414d-9355-64b47c86d77d" xlink:href="med-20220930.xsd#med_AmortizationOfPremiumOnInvestmentSecurities"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_med_AmortizationOfPremiumOnInvestmentSecurities_348a915e-2b56-414d-9355-64b47c86d77d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3fe03e2a-079a-42a4-b5c9-2a40dedca2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
<link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3fe03e2a-079a-42a4-b5c9-2a40dedca2af" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_381a3287-9f2f-4313-8b6c-d2e460a4bbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
<link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_381a3287-9f2f-4313-8b6c-d2e460a4bbf3" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e1df90c1-16d2-48b0-a0ae-440a8b609ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e1df90c1-16d2-48b0-a0ae-440a8b609ed1" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_06ce5d8c-d4a5-43d7-b187-f951b5f44fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
<link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_06ce5d8c-d4a5-43d7-b187-f951b5f44fd7" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ac3cfd64-3e6c-435d-9671-ad7b2c9fbc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ac3cfd64-3e6c-435d-9671-ad7b2c9fbc32" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0c3ef6a0-125d-4005-9647-822092938a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
<link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f009398-b8ac-4633-95d0-6540797a7f66" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0c3ef6a0-125d-4005-9647-822092938a55" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_e505bee9-2cf9-41c9-95f5-79f6c10ad3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_e505bee9-2cf9-41c9-95f5-79f6c10ad3d9" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_45e1379f-caa7-4a8c-b3dd-7134479a96f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_45e1379f-caa7-4a8c-b3dd-7134479a96f3" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c4f5f061-0415-491b-b147-162d58333d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c4f5f061-0415-491b-b147-162d58333d20" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f11752f8-28ea-4d7e-9071-18986c4f52c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
<link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa4d523a-72a0-4f8c-97e1-261706348c61" xlink:to="loc_us-gaap_PaymentsOfDividends_f11752f8-28ea-4d7e-9071-18986c4f52c6" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="med-20220930.xsd#INVENTORIESDetails"/>
<link:calculationLink xlink:role="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_9653ff09-b11a-4008-a1c8-d8b6107f1786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_us-gaap_InventoryRawMaterials_9653ff09-b11a-4008-a1c8-d8b6107f1786" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_d8237071-b18d-4198-93dd-fb1f5cd6b567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_d8237071-b18d-4198-93dd-fb1f5cd6b567" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods_14744e0e-d55f-4ad4-9ade-9ea0bec2005f" xlink:href="med-20220930.xsd#med_InventoryNonFoodFinishedGoods"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_med_InventoryNonFoodFinishedGoods_14744e0e-d55f-4ad4-9ade-9ea0bec2005f" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_43d68f31-1f53-498e-a0c4-6c18882a7a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_us-gaap_InventoryFinishedGoods_43d68f31-1f53-498e-a0c4-6c18882a7a16" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_ee25f957-041b-43b8-b466-9b82ada310bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
<link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_aee1da26-2f74-4d02-9c3f-dca0d8abf459" xlink:to="loc_us-gaap_InventoryValuationReserves_ee25f957-041b-43b8-b466-9b82ada310bf" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="med-20220930.xsd#EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"/>
<link:calculationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f4498d88-7e3f-4960-a15b-d47df111a9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b57db3ba-5efe-422e-bec9-89cab9f8919b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f4498d88-7e3f-4960-a15b-d47df111a9b5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b57db3ba-5efe-422e-bec9-89cab9f8919b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f10ae389-cc54-449c-abd8-c4f660c1043b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f4498d88-7e3f-4960-a15b-d47df111a9b5" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f10ae389-cc54-449c-abd8-c4f660c1043b" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESFutureMinimumLeaseCommitmentsDetails"/>
<link:calculationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_eeec93ff-ec5f-4d5a-90b8-b88e03d3a1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_eeec93ff-ec5f-4d5a-90b8-b88e03d3a1ae" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_375d0973-0569-49bc-9ae7-683015fc677d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_375d0973-0569-49bc-9ae7-683015fc677d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_355f11a0-5fc9-4a7e-aaa3-ab4cd90a06b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_355f11a0-5fc9-4a7e-aaa3-ab4cd90a06b9" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_13dcc5b1-9dd9-4772-bde3-98b5e8e3c5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_13dcc5b1-9dd9-4772-bde3-98b5e8e3c5f5" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7324adc9-405e-40f4-94d2-92953624c62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7324adc9-405e-40f4-94d2-92953624c62d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_10584ae6-79f5-4f58-bb4f-3fd26c963b7e" xlink:href="med-20220930.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive"/>
<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60842d76-fb83-44e4-bfad-e4a690bd38d7" xlink:to="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_10584ae6-79f5-4f58-bb4f-3fd26c963b7e" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="med-20220930.xsd#LEASESFutureMinimumLeaseCommitmentsDetails_1"/>
<link:calculationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d68f55-31c4-418c-a2de-f2547f4f71f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_83df2a5e-cc8e-4e2f-be56-769aab478194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d68f55-31c4-418c-a2de-f2547f4f71f7" xlink:to="loc_us-gaap_OperatingLeaseLiability_83df2a5e-cc8e-4e2f-be56-769aab478194" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0d3f4ff0-f63d-4bd9-8c46-eabc01be7ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9d68f55-31c4-418c-a2de-f2547f4f71f7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0d3f4ff0-f63d-4bd9-8c46-eabc01be7ba0" xlink:type="arc"/>
</link:calculationLink>
</link:linkbase>

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/04/19  Medifast Inc.                     8-K/A:9     6/12/19   11:412K                                   Toppan Merrill/FA
 2/27/15  Medifast Inc.                     8-K:5,9     2/17/15    4:89K                                    Toppan Merrill/FA
↑Top
Filing Submission 0001628280-22-028255   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 3, 10:01:54.2pm ET